SURVEYING THE DEVELOPMENT OF INSOMNIA IN PHARMACY STUDENTS INFECTED WITH COVID-19 AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY

Minh Tiến Nguyễn , Thiện Khoa Huỳnh , Anh Khoa Nguyễn , Hà Phương Lại , Đăng Khoa Lý , Yên Hảo Trần , Duy Khánh Đặng

Main Article Content

Abstract

Objective: To identify the rate of insomnia and factors related to insomnia in Pharmacy students infected with COVID-19 at Can Tho University of Medicine and Pharmacy using the insomnia severity index (ISI). Methods: An analytical cross-sectional study on 343 Pharmacy students studying at Can Tho University of Medicine and Pharmacy who were and were not infected with COVID-19 from July 2022 to October 2022. Results: No relationship was found between personal characteristics such as year of study, gender, place of residence, financial situation, quarantine situation, and use of COVID-19 medication and students' insomnia. The proportion of students infected with COVID-19 having insomnia (50.9%) was higher than that of students not infected (49.1%) (RR = 1.01; 95%CI = 0 .87 - 1.17). Conclusion: Personal characteristics and social relationships are unrelated to insomnia; however, COVID-19 infection may be a risk factor affecting Pharmacy students' sleep.

Article Details

References

1. Alrashed, F. A., Sattar, K., Ahmad, T., Akram, A., Karim, S. I., & Alsubiheen, A. M. Prevalence of insomnia and related psychological factors with coping strategies among medical students in clinical years during the COVID-19 pandemic. Saudi journal of biological sciences. 2021; 28(11):6508-6514.
2. Baharun, H., et al. Depression and coping strategies during COVID-19 pandemic among university students in Malaysia. Int. J. Environ. Res. Public Health. 2022; 19(8):4711.
3. Lee, L.Y., et al. Impacts of COVID-19 on the mental health of university students in Singapore. Int J Environ Res Public Health. 2021; 18(17):8993.
4. Lima, M. G., Barros, M. B. A., Szwarcwald, C. L., Malta, D. C., Romero, D. E., Werneck, A. O., & Souza Júnior, P. R. B. Association of social and economic conditions with the incidence of sleep disorders during the COVID-19 pandemic. Cadernos de saude publica. 2021; 37(3): e00218320.
5. Morin, C. M., Belleville, G., Bélanger, L., & Ivers, H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011; 34(5):601-608.
6. Moura, A. E. F., Oliveira, D. N., Torres, D. M., Tavares-Júnior, J. W. L., Nóbrega, P. R., Braga-Neto, P., & Sobreira-Neto, M. A. Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome-a prospective cohort study. BMC neurology. 2022; 22(1):1-10.
7. Pilotto, A., Cristillo, V., Cotti Piccinelli, S., Zoppi, N., Bonzi, G., Sattin, D., Padovani, A. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurological Sciences. 2021; 42:4903-4907.
8. Wang, Q., Xu, R. and Volkow, N.D. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2020; 20:124-130.